Dexcom reports 2025 revenues of $4.66bn yet 2026 outlook lags analyst expectations

robot
Abstract generation in progress

Dexcom reported strong 2025 revenues of $4.66bn, driven by demand for its continuous glucose monitoring systems, with Q4 2025 earnings at $1.26bn. Despite this, the company’s 2026 revenue forecast of $5.16bn to $5.25bn, while showing double-digit growth, fell slightly below analysts’ expectations. CEO Jake Leach outlined plans for 2026, including increasing awareness of the new G7 15-day device, enhancing customer experience, and expanding international market share, particularly with the Smart Basal launch.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin

Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский язык
  • Français
  • Deutsch
  • Português (Portugal)
  • ภาษาไทย
  • Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)